BioSpace News Archive

AirPhysio COPD Symptom/Mucus Buildup Relief – OPEP Breathing Device Launched

The online store’s newly restocked AirPhysio breathing device is recommended for those who suffer from COPD due to smoking and want to get rid of extra mucus and strengthen their lungs.

January 4, 2022
·
2 min read
Drug Development

Alentis Therapeutics Starts First-in-Human Clinical Trial for the Treatment of Liver and Kidney Fibrosis

Alentis Therapeutics, AG announced it has dosed the first cohort of healthy participants in a first-in-human Phase 1 clinical trial of ALE.F02, a monoclonal antibody highly selective for Claudin-1, currently being developed for the treatment of advanced unmet liver and kidney fibrosis.

January 4, 2022
·
3 min read
Deals

Calibre Scientific Acquires AmpliTech, a French Distributor of Reagents and Instruments Specializing in Molecular Pathology, Cytogenetics, and Molecular Genetics

Calibre Scientific is pleased to announce the acquisition of AmpliTech, a distributor of reagents and instruments to research and diagnostic laboratories with headquarters in Compiègne, France.

January 4, 2022
·
2 min read
Pharm Country

Baudax Bio to Present at the H.C. Wainwright BIOCONNECT Virtual Conference

Baudax Bio, Inc. announced that Gerri Henwood, the Company’s President and Chief Executive Officer, will present at the H.C. Wainwright BIOCONNECT Virtual Conference being held January 10 - 13, 2022.

January 4, 2022
·
1 min read
Genetown

Orchard Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference

Orchard Therapeutics (Nasdaq: ORTX), a global gene therapy leader, today announced that the company is scheduled to present at the virtual 40th Annual J.P. Morgan Healthcare Conference on Thursday January 13, 2022, at 9:00 a.m. ET.

January 4, 2022
·
2 min read
Genetown

Decibel Therapeutics to Present at the H.C. Wainwright BioConnect Conference

Decibel Therapeutics announced that Laurence Reid, Ph.D., Chief Executive Officer of Decibel, will participate in a fireside chat at the H.C. Wainwright BioConnect Conference.

January 4, 2022
·
1 min read
Biotech Bay

ALX Oncology to Present at the 40th Annual J.P. Morgan Healthcare Conference

ALX Oncology Holdings Inc., (“ALX Oncology”) (Nasdaq: ALXO), today announced that Jaume Pons, Ph.D., Founder, President and Chief Executive Officer, will virtually present a company overview at the 40th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11 at 10:30 am ET.

January 4, 2022
·
1 min read
Genetown

Finch Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference and H.C. Wainwright BioConnect Conference

Finch Therapeutics Group, Inc. today announced that Mark Smith, PhD, Chief Executive Officer, will present a corporate overview at the virtual 40th Annual J.P. Morgan Healthcare Conference on Thursday, January 13, 2022 at 9:45 a.m.

January 4, 2022
·
1 min read
Business

PROCEPT BioRobotics Appoints Mary Garrett to Board of Directors

PROCEPT ® BioRobotics Corporation today announced the appointment of Mary Garrett to its Board of Directors.

January 4, 2022
·
2 min read
Bio NC

BioCryst to Present at 40th Annual J.P. Morgan Healthcare Conference

BioCryst Pharmaceuticals, Inc. today announced that the company will present at the 40th Annual J.P. Morgan Healthcare Conference, which is being conducted as a virtual event, on Monday, January 10, 2022 at 9:45 a.m. ET.

January 4, 2022
·
1 min read